Deep mRNA Sequencing for In Vivo Functional Analysis of Cardiac Transcriptional Regulators Application to Gαq

Deep mRNA Sequencing for In Vivo Functional Analysis of Cardiac Transcriptional Regulators Application to Gαq
复制标题

DOI:
10.1161/circresaha.110.217513
复制
发表时间:
2010-05-14
影响因子:
20.1
通讯作者:
Dorn, Gerald W., II
Dorn, Gerald W., II
中科院分区:
医学1区
文献类型:
--
作者:
Matkovich, Scot J.;Zhang, Yan;Dorn, Gerald W., II

文献摘要

被引文献

相似文献

基本原理:转录谱可以检测亚临床心脏病,并提供疾病病因和功能状态的见解。目前的微阵列为基础的方法是昂贵的,并受到artifaction.Objective:开发RNA测序方法,使用下一代大规模并行平台的高通量全面分析个别小鼠心脏转录组。比较测序和阵列为基础的转录分析的结果,在良好的特点G α q转基因小鼠肥大/cardiomyopathy model.Methods和Results:的技术制备单独的条形码小鼠心脏RNA库的Illumina基因组分析仪II重测序。RNA测序显示,234个高丰度转录物(>60拷贝/细胞)占总心脏mRNA的55%。通过Illumina RNA测序和Affyssin Mouse Gene 1.0 ST阵列对G alpha q转基因和非转基因心脏进行的平行转录谱分析显示,mRNA表达的动态范围上级,并且通过RNA测序报告低丰度转录本的特异性增强。基因芯片和RNA测序高度丰富的转录本之间G α q和非转基因心脏的差异mRNA表达相关性良好。RNA测序是上级阵列准确定量低丰度的基因,这代表了大多数的G α q转基因model.Conclusions调控基因:RNA测序是快速,准确,灵敏的识别丰富和罕见的心脏转录,并具有显着的优势,在时间和成本效益的微阵列分析。(Circ Res. 2010; 106:1459-1467)。
Rationale: Transcriptional profiling can detect subclinical heart disease and provide insight into disease etiology and functional status. Current microarray-based methods are expensive and subject to artifact.Objective: To develop RNA sequencing methodologies using next generation massively parallel platforms for high throughput comprehensive analysis of individual mouse cardiac transcriptomes. To compare the results of sequencing- and array-based transcriptional profiling in the well-characterized G alpha q transgenic mouse hypertrophy/cardiomyopathy model.Methods and Results: The techniques for preparation of individually bar-coded mouse heart RNA libraries for Illumina Genome Analyzer II resequencing are described. RNA sequencing showed that 234 high-abundance transcripts (>60 copies/cell) comprised 55% of total cardiac mRNA. Parallel transcriptional profiling of G alpha q transgenic and nontransgenic hearts by Illumina RNA sequencing and Affymetrix Mouse Gene 1.0 ST arrays revealed superior dynamic range for mRNA expression and enhanced specificity for reporting low-abundance transcripts by RNA sequencing. Differential mRNA expression in G alpha q and nontransgenic hearts correlated well between microarrays and RNA sequencing for highly abundant transcripts. RNA sequencing was superior to arrays for accurately quantifying lower-abundance genes, which represented the majority of the regulated genes in the G alpha q transgenic model.Conclusions: RNA sequencing is rapid, accurate, and sensitive for identifying both abundant and rare cardiac transcripts, and has significant advantages in time-and cost-efficiencies over microarray analysis. (Circ Res. 2010; 106:1459-1467.)